Recent Company News

• 09:18 AM ET Jul 24, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:23 AM ET Jul 24, 2025
  

  StreetAccount Summary - US Pre-market trading

• 04:07 AM ET Jul 24, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:31 AM ET Aug 06, 2025
  

  Galapagos NV Announces US FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma (€28.76, 0.00)

• 03:18 PM ET Aug 05, 2025
  

  Galapagos downgraded to sell from hold at Deutsche Bank ($32.76, -0.63)

• 10:03 AM ET Aug 05, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (147 total)

• 04:28 PM ET Jul 24, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market